• G00258
• G13014

RES
1b:b-dglc-HEX-1:5
2b:b-dgal-HEX-1:5
3b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d
4s:n-glycolyl
LIN
1:1o(4+1)2d
2:2o(3+2)3d
3:3d(5+1)4n

• Ozawa H et al. Generation of murine monoclonal antibodies specific for N-glycolylneuraminic acid-containing gangliosides. Arch Biochem Biophys. 1992 May 1;294:(2):427-33. doi: 10.1016/0003-9861(92)90707-4. PMID: 1567198.

• Kawashima I et al. Characterization of ganglioside expression in human melanoma cells: immunological and biochemical analysis. J Biochem. 1993 Aug;114:(2):186-93. doi: 10.1093/oxfordjournals.jbchem.a124153. PMID: 8262898.

• Carr A et al. A mouse IgG1 monoclonal antibody specific for N-glycolyl GM3 ganglioside recognized breast and melanoma tumors. Hybridoma. 2000 Jun;19:(3):241-7. doi: 10.1089/02724570050109639. PMID: 10952412.

• Watarai S et al. Production of monoclonal antibodies directed to Hanganutziu-Deicher active gangliosides, N-glycolylneuraminic acid-containing gangliosides. J Biochem. 1995 May;117:(5):1062-9. doi: 10.1093/oxfordjournals.jbchem.a124807. PMID: 8586620.

• Furukawa K et al. Analysis of the expression of N-glycolylneuraminic acid-containing gangliosides in cells and tissues using two human monoclonal antibodies. J Biol Chem. 1988 Dec 5;263:(34):18507-12. PMID: 3192544.